PET Imaging of Cancer Patients Using 124I-PUH71: A Pilot Study
Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see how a new drug, named PUH71, accumulates in the different
parts of the body & inside tumors and how long PUH71 lasts in the blood, when given to study
participants in tiny amounts. The results of this study will help researchers (1) plan how
they will use PUH71 as an experimental new drug (at much-higher doses) for the treatment of
cancer, in clinical trials; and (2) know whether PUH71 might be used as a drug for detecting
tumors with scanner machines.